Literature DB >> 17125268

Selective angiotensin II AT2 receptor agonists: arylbenzylimidazole structure-activity relationships.

Xiongyu Wu1, Yiqian Wan, A K Mahalingam, A M S Murugaiah, Bianca Plouffe, Milad Botros, Anders Karlén, Mathias Hallberg, Nicole Gallo-Payet, Mathias Alterman.   

Abstract

Structural alterations in the 2- and 5-positions of the first drug-like selective angiotensin II AT2 receptor agonist (1) have been performed. The imidazole ring system was proven to be a strong determinant for the AT2 selectivity, and with few exceptions all variations gave good AT2 receptor affinities and with retained high AT2/AT1 selectivities. On the contrary to the findings with AT1 receptor agonists, the impact of structural modifications in the 5-position of the AT2 selective compounds were less pronounced regarding activation of the AT2 receptor. The butyloxyphenyl (56) and the propylthienyl (50) derivatives were found to exert a high agonistic effect as deduced from their capacity to induce neurite elongation in neuronal cells, as does angiotensin II.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17125268     DOI: 10.1021/jm0606185

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Interconversion of Functional Activity by Minor Structural Alterations in Nonpeptide AT2 Receptor Ligands.

Authors:  Charlotta Wallinder; Christian Sköld; Milad Botros; Marie-Odile Guimond; Mathias Hallberg; Nicole Gallo-Payet; Anders Karlén; Mathias Alterman
Journal:  ACS Med Chem Lett       Date:  2014-12-08       Impact factor: 4.345

Review 2.  The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Authors:  U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

3.  A Novel Cellular Model to Study Angiotensin II AT2 Receptor Function in Breast Cancer Cells.

Authors:  Sylvie Rodrigues-Ferreira; Marina Morel; Rosana I Reis; Françoise Cormier; Véronique Baud; Claudio M Costa-Neto; Clara Nahmias
Journal:  Int J Pept       Date:  2011-12-06

4.  Angiotensin II, a Neuropeptide at the Frontier between Endocrinology and Neuroscience: Is There a Link between the Angiotensin II Type 2 Receptor and Alzheimer's Disease?

Authors:  Nicole Gallo-Payet; Marie-Odile Guimond; Lyne Bilodeau; Charlotta Wallinder; Mathias Alterman; Anders Hallberg
Journal:  Front Endocrinol (Lausanne)       Date:  2011-08-26       Impact factor: 5.555

5.  A Series of Analogues to the AT2R Prototype Antagonist C38 Allow Fine Tuning of the Previously Reported Antagonist Binding Mode.

Authors:  Rebecka Isaksson; Jens Lindman; Johan Wannberg; Jessica Sallander; Maria Backlund; Dhaniel Baraldi; Robert Widdop; Mathias Hallberg; Johan Åqvist; Hugo Gutierrez de Teran; Johan Gising; Mats Larhed
Journal:  ChemistryOpen       Date:  2019-01-24       Impact factor: 2.911

6.  Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists.

Authors:  Silvana Vasile; Anders Hallberg; Jessica Sallander; Mathias Hallberg; Johan Åqvist; Hugo Gutiérrez-de-Terán
Journal:  Biomolecules       Date:  2020-04-23

7.  An insight into the pharmacophores of phosphodiesterase-5 inhibitors from synthetic and crystal structural studies.

Authors:  Gong Chen; Huanchen Wang; Howard Robinson; Jiwen Cai; Yiqian Wan; Hengming Ke
Journal:  Biochem Pharmacol       Date:  2008-02-12       Impact factor: 5.858

8.  Direct angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPARγ activation.

Authors:  Kousei Ohshima; Masaki Mogi; Fei Jing; Jun Iwanami; Kana Tsukuda; Li-Juan Min; Akiyoshi Ogimoto; Björn Dahlöf; Ulrike M Steckelings; Tomas Unger; Jitsuo Higaki; Masatsugu Horiuchi
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

9.  Discovery of inhibitors of insulin-regulated aminopeptidase as cognitive enhancers.

Authors:  Hanna Andersson; Mathias Hallberg
Journal:  Int J Hypertens       Date:  2012-12-04       Impact factor: 2.420

10.  The Angiotensin II Type 2 Receptor in Brain Functions: An Update.

Authors:  Marie-Odile Guimond; Nicole Gallo-Payet
Journal:  Int J Hypertens       Date:  2012-12-25       Impact factor: 2.420

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.